Nasogastric Tube – Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
Global Leading Market Research Publisher QYResearch announces the release of its latest report “Nasogastric Tube – Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032”. Based on current situation and historical impact analysis (2021-2025) alongside forecast calculations (2026-2032), this report delivers an in-depth evaluation of the global Nasogastric Tube (NG Tube) market, covering market size, market share, demand trends, industry dynamics, and future growth projections.
The global market for Nasogastric Tubes was valued at US$ 279 million in 2025 and is projected to reach US$ 338 million by 2032, growing at a CAGR of 2.8% from 2026 to 2032. Growth is fueled by rising hospitalizations, increasing prevalence of gastrointestinal disorders, and expanded usage of NG tubes in pediatric and adult critical care units.
【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)】
https://www.qyresearch.com/reports/5495833/nasogastric-tube
Product Definition and Clinical Overview
A Nasogastric Tube (NG Tube) is a flexible medical device passed through the nose, down the nasopharynx and esophagus, and into the stomach. NG tubes are primarily made of rubber or medical-grade plastic, and they serve both diagnostic and therapeutic functions.
Key applications include:
- Gastric Decompression: Removing air, fluid, or small solid objects from the stomach, which is critical for patients with bowel obstruction or gastric distension.
- Gastrointestinal Lavage: Used in emergency cases, such as poisoning, to remove toxic substances.
- Nutrient Administration: Facilitating direct delivery of nutrients, electrolytes, or medications when oral intake is not possible.
NG tubes are also versatile in terms of patient demographics and clinical settings, supporting both pediatric and adult care across hospitals, long-term care facilities, and outpatient centers.
Market Size, Growth Drivers, and Forecast
The NG Tube market shows stable growth, with a forecasted CAGR of 2.8% from 2026 to 2032. Key drivers include:
- Aging Population: Growing geriatric population with increased incidence of chronic gastrointestinal conditions requiring long-term enteral feeding.
- Rising Hospital Admissions: Expanding critical care infrastructure globally, especially in Europe, North America, and Asia, drives demand for disposable and reusable NG tubes.
- Technological Advancements: Improved tube materials, safety features such as anti-kinking designs, and single-use options reduce infection risk, enhancing adoption.
- Medical Tourism and Healthcare Expansion: Rising healthcare investments in emerging markets increase NG tube deployment in hospitals and specialty care centers.
Regionally, Europe dominates, contributing approximately 25% of global revenue, largely due to advanced healthcare infrastructure, high standards of critical care, and strong adoption of disposable NG tubes. China and North America combined represent nearly 49% of the market, driven by a high volume of hospital admissions, expanding critical care units, and increasing government healthcare expenditure.
Competitive Landscape
The Nasogastric Tube market is moderately fragmented, with key players focusing on product innovation, strategic collaborations, and geographic expansion. Bard Medical, the largest manufacturer, holds approximately 5% of global revenue market share, followed closely by other major players:
- Andersen Products – Known for precision-engineered NG tubes with high safety standards.
- Bicakcilar – Strong presence in European and Middle Eastern markets with cost-effective solutions.
- Degania Silicone – Specializes in biocompatible silicone tubes for long-term use.
- Rontis Medical – Offers pediatric and adult NG tubes with anti-kinking and anti-reflux features.
- Guangdong Baihe Medical Technology & Pacific Hospital Supply – Key players in Asia, expanding market penetration through government tenders and hospital partnerships.
Top three companies collectively account for approximately 14% of the global revenue, highlighting a competitive environment where innovation and regulatory compliance are key differentiators.
Market Segmentation
By Type:
- Levin Tube – The standard NG tube widely used for decompression and feeding.
- Sengstaken-Blakemore Tube – Specialized NG tube for controlling esophageal variceal bleeding.
- Others – Include dual-lumen, anti-reflux, and single-use variations designed for niche clinical requirements.
By Application:
- Children Use – Pediatric-specific NG tubes designed with reduced diameter and flexibility for safety.
- Adult Use – Standard and specialized NG tubes for adults, supporting feeding, medication, and emergency care.
Industry Trends and Opportunities
- Disposable NG Tubes: Increasing preference for single-use devices due to infection control and regulatory requirements.
- Advanced Materials: Adoption of biocompatible polymers and anti-kinking designs improves patient safety and tube longevity.
- Integration with Enteral Feeding Systems: Manufacturers are developing NG tubes compatible with automated feeding pumps and monitoring systems.
- Emerging Markets: Rising hospital infrastructure and healthcare spending in India, Southeast Asia, and Africa provide significant growth opportunities.
- Regulatory Compliance: Stringent FDA and EU MDR certifications ensure safety, creating a barrier for low-quality competitors while reinforcing trust in premium brands.
Challenges
- Low Pricing Pressure: In some emerging markets, cost constraints limit adoption of premium NG tubes.
- Supply Chain Complexity: Sterilization, packaging, and logistics require strict quality control, adding operational costs.
- Clinical Training: Proper insertion and monitoring require skilled personnel, limiting adoption in under-resourced facilities.
- Competition from Alternative Enteral Devices: Nasoduodenal or percutaneous feeding tubes may replace NG tubes in specialized long-term care scenarios.
Strategic Outlook
The global Nasogastric Tube market is expected to grow steadily through 2032. Companies that emphasize innovation, compliance, and regional penetration will maintain competitive advantages. Opportunities for growth include:
- Partnerships with Hospitals and Government Programs: Secure bulk procurement contracts for disposable NG tubes.
- R&D Investments: Develop silicone-based, anti-reflux, and dual-lumen NG tubes that reduce complications and enhance patient comfort.
- Expansion into Emerging Markets: Focus on China, India, and Southeast Asia to capitalize on increasing healthcare infrastructure investments.
Conclusion
The Nasogastric Tube market, valued at US$ 279 million in 2025, is projected to reach US$ 338 million by 2032 at a CAGR of 2.8%. Steady growth is driven by rising critical care needs, hospital expansion, and technological advancements in tube materials and design. Leading players such as Bard Medical, Andersen Products, and Bicakcilar dominate the market, while innovation, regulatory compliance, and emerging market penetration are poised to define future market leaders.
Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
E-mail: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp
